In APP/PS1 mice, a model of AD, agents that inhibit NLRP3 improve spatial memory function/synaptic plasticity/dendritic spine number and suppress microglial activation/proinflammatory cytokine expression (7). The gene discussed is NLRP3; the disease is Alzheimer disease.